Fundació per a la Recerca Biomedica Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2013
NCT02214862
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

fddnp (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 1)

Multiple System Atrophy (Phase 1)

Parkinsonian Disorders (Phase 1)

Shy-Drager Syndrome (Phase 1)

Supranuclear Palsy, Progressive (Phase 1)

Tauopathies (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1